Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2026-01-12 00:00:00 ET · period of report 2026-01-08 · accession 0001470831-26-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-01-12 | 2026-01-08+ | BBIO | Kumar Neil | CEO, Dir | S - Sale | $75.54 | -80.0K | 4.54M | -2% | -$6.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-08 | S | D | 11,515 | $73.64 | 744,171 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F2) Represents the weighted average sale price of the shares sold from $73.05 to $74.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 2 | Common | Common Stock | 2026-01-09 | S | D | 2,151 | $75.75 | 733,535 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F8) Represents the weighted average sale price of the shares sold from $75.12 to $76.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 3 | Common | Common Stock | 2026-01-08 | S | D | 400 | $75.16 | 735,686 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F5) Represents the weighted average sale price of the shares sold from $75.09 to $75.28 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 4 | Common | Common Stock | 2026-01-08 | S | D | 8,085 | $74.38 | 736,086 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F4) Represents the weighted average sale price of the shares sold from $74.06 to $74.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 5 | Common | Common Stock | 2026-01-08 | S | D | 300 | $75.20 | 4,538,447 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F5) Represents the weighted average sale price of the shares sold from $75.09 to $75.28 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 6 | Common | Common Stock | 2026-01-09 | S | D | 1,855 | $78.10 | 4,518,447 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F15) Represents the weighted average sale price of the shares sold from $78.00 to $78.32 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 7 | Common | Common Stock | 2026-01-09 | S | D | 10,677 | $77.46 | 4,520,302 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F14) Represents the weighted average sale price of the shares sold from $76.99 to $77.96 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 8 | Common | Common Stock | 2026-01-09 | S | D | 6,067 | $76.53 | 4,530,979 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F13) Represents the weighted average sale price of the shares sold from $75.99 to $76.985 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 9 | Common | Common Stock | 2026-01-09 | S | D | 1,401 | $75.61 | 4,537,046 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F12) Represents the weighted average sale price of the shares sold from $74.99 to $75.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 10 | Common | Common Stock | 2026-01-09 | S | D | 375 | $78.19 | 715,686 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F11) Represents the weighted average sale price of the shares sold from $78.16 to $78.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 11 | Common | Common Stock | 2026-01-09 | S | D | 10,519 | $77.61 | 716,061 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F10) Represents the weighted average sale price of the shares sold from $77.16 to $78.12 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 12 | Common | Common Stock | 2026-01-09 | S | D | 6,955 | $76.72 | 726,580 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F9) Represents the weighted average sale price of the shares sold from $76.13 to $77.125 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 13 | Common | Common Stock | 2026-01-08 | S | D | 11,565 | $73.65 | 4,546,882 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F6) Represents the weighted average sale price of the shares sold from $73.08 to $74.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |
| 14 | Common | Common Stock | 2026-01-08 | S | D | 8,135 | $74.38 | 4,538,747 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F7) Represents the weighted average sale price of the shares sold from $74.08 to $75.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. (F3) The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. |